Analysts expect that Healthequity Inc (NASDAQ:HQY) will announce $0.19 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Healthequity’s earnings. The lowest EPS estimate is $0.15 and the highest is $0.23. Healthequity posted earnings per share of $0.27 in the same quarter last year, which indicates a negative year-over-year growth rate of 29.6%. The company is scheduled to announce its next quarterly earnings report on Monday, March 16th.
According to Zacks, analysts expect that Healthequity will report full-year earnings of $1.42 per share for the current financial year, with EPS estimates ranging from $1.15 to $1.52. For the next financial year, analysts expect that the firm will report earnings of $1.59 per share, with EPS estimates ranging from $0.93 to $2.00. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that that provide coverage for Healthequity.
Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, December 3rd. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.33. Healthequity had a net margin of 13.03% and a return on equity of 11.31%. The company had revenue of $157.12 million during the quarter, compared to analysts’ expectations of $152.38 million. During the same quarter in the previous year, the business posted $0.25 earnings per share. The firm’s quarterly revenue was up 122.9% compared to the same quarter last year.
HQY has been the topic of a number of recent research reports. Wells Fargo & Co reduced their target price on Healthequity from $80.00 to $76.00 and set an “outperformer” rating on the stock in a research note on Wednesday, September 4th. Cantor Fitzgerald reissued a “buy” rating and set a $95.00 price target on shares of Healthequity in a research report on Wednesday, December 4th. Oppenheimer cut their price target on Healthequity from $98.00 to $76.00 and set an “outperform” rating for the company in a report on Wednesday, September 4th. KeyCorp restated a “buy” rating and issued a $77.00 price objective (up from $70.00) on shares of Healthequity in a research report on Wednesday, December 4th. Finally, Goldman Sachs Group began coverage on Healthequity in a research report on Monday, October 7th. They issued a “neutral” rating and a $56.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $77.86.
Shares of HQY opened at $68.73 on Friday. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.91 and a quick ratio of 1.91. Healthequity has a 1-year low of $50.29 and a 1-year high of $85.07. The stock has a market cap of $4.75 billion, a price-to-earnings ratio of 72.35, a price-to-earnings-growth ratio of 2.36 and a beta of 1.47. The firm has a 50 day simple moving average of $61.33 and a 200-day simple moving average of $64.11.
In related news, CFO Darcy G. Mott sold 4,000 shares of the stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $61.61, for a total transaction of $246,440.00. Following the transaction, the chief financial officer now directly owns 46,000 shares in the company, valued at $2,834,060. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 12,000 shares of company stock valued at $715,600 over the last quarter. 3.70% of the stock is currently owned by insiders.
A number of hedge funds have recently modified their holdings of HQY. Metropolitan Life Insurance Co NY increased its holdings in shares of Healthequity by 27.1% during the 3rd quarter. Metropolitan Life Insurance Co NY now owns 40,209 shares of the company’s stock worth $2,298,000 after buying an additional 8,567 shares during the last quarter. Millennium Management LLC boosted its holdings in Healthequity by 84.3% in the third quarter. Millennium Management LLC now owns 261,859 shares of the company’s stock valued at $14,963,000 after acquiring an additional 119,758 shares during the last quarter. Squarepoint Ops LLC grew its position in Healthequity by 11.4% during the third quarter. Squarepoint Ops LLC now owns 51,478 shares of the company’s stock valued at $2,942,000 after acquiring an additional 5,285 shares during the period. Granahan Investment Management Inc. MA grew its position in Healthequity by 29.7% during the third quarter. Granahan Investment Management Inc. MA now owns 602,767 shares of the company’s stock valued at $34,445,000 after acquiring an additional 138,045 shares during the period. Finally, Public Employees Retirement System of Ohio grew its position in Healthequity by 13.3% during the third quarter. Public Employees Retirement System of Ohio now owns 103,556 shares of the company’s stock valued at $5,918,000 after acquiring an additional 12,132 shares during the period. 95.97% of the stock is owned by hedge funds and other institutional investors.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also: What is quantitative easing?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.